HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Ro 24-0238

PAF antagonist

Also Known As:

5-(4-methoxyphenyl)-N-(1-methyl-4-(3-pyridinyl)butyl)-2,4-decadienamide; Ro-24-0238

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Ro 24-0238: 2
Organic Chemicals: 133
- Amides: 2428
  - Polyunsaturated Alkamides
    - Ro 24-0238: 2
- Hydrocarbons: 1713
  - Acyclic Hydrocarbons
    - Alkenes: 265
      - Polyunsaturated Alkamides
        Ro 24-0238: 2
    - Alkynes: 217
      - Polyunsaturated Alkamides
        Ro 24-0238: 2

Related Diseases

1.	Colitis 09/01/1991 - "The role of PAF as a proinflammatory mediator was examined by measuring the production of PAF and the efficacy of the PAF antagonists WEB 2086 and Ro 24-0238 in acetic acid (HOAc)-induced colitis. "
2.	Psoriasis (Pustulosis Palmaris et Plantaris) 11/01/1994 - "The effect of topical application of the platelet-activating factor-antagonist, Ro 24-0238, in psoriasis vulgaris--a clinical and immunohistochemical study." 11/01/1994 - "The objective of this study was to investigate the effect of a potent PAF-antagonist (Ro 24-0238, 10% solution in diethylene glycol monoethyl ether) in 10 patients with chronic plaque psoriasis, a placebo-controlled double-blind study. "

Related Drugs and Biologics

1.	Acetic Acid (Vinegar)
2.	WEB 2086 (apafant)
3.	Solutions
4.	Platelet Activating Factor
5.	carbitol (diethylene glycol monoethyl ether)